Company’s 36-month beta value is 1.32.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for LFST is 86.33M, and currently, short sellers hold a 21.62% ratio of that floaft. The average trading volume of LFST on May 09, 2024 was 1.22M shares.
LFST) stock’s latest price update
The stock price of LifeStance Health Group Inc (NASDAQ: LFST) has dropped by 0.00 compared to previous close of 6.98. Despite this, the company has seen a gain of 8.22% in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-18 that SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) — LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its first quarter 2024 earnings release before the market opens on Thursday, May 9, 2024.
LFST’s Market Performance
LifeStance Health Group Inc (LFST) has experienced a 8.22% rise in stock performance for the past week, with a 10.97% rise in the past month, and a 16.14% rise in the past quarter. The volatility ratio for the week is 3.48%, and the volatility levels for the past 30 days are at 3.85% for LFST.. The simple moving average for the past 20 days is 13.15% for LFST’s stock, with a 1.99% simple moving average for the past 200 days.
Analysts’ Opinion of LFST
Many brokerage firms have already submitted their reports for LFST stocks, with Barclays repeating the rating for LFST by listing it as a “Underweight.” The predicted price for LFST in the upcoming period, according to Barclays is $7 based on the research report published on January 03, 2024 of the current year 2024.
TD Cowen, on the other hand, stated in their research note that they expect to see LFST reach a price target of $9, previously predicting the price at $8. The rating they have provided for LFST stocks is “Market Perform” according to the report published on May 15th, 2023.
Morgan Stanley gave a rating of “Overweight” to LFST, setting the target price at $8 in the report published on January 06th of the previous year.
LFST Trading at 8.02% from the 50-Day Moving Average
After a stumble in the market that brought LFST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.22% of loss for the given period.
Volatility was left at 3.85%, however, over the last 30 days, the volatility rate increased by 3.48%, as shares surge +13.68% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.18% upper at present.
During the last 5 trading sessions, LFST rose by +8.22%, which changed the moving average for the period of 200-days by -22.53% in comparison to the 20-day moving average, which settled at $6.21. In addition, LifeStance Health Group Inc saw -10.86% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LFST starting from Qureshi Danish J., who sale 12,965 shares at the price of $5.93 back on Apr 01 ’24. After this action, Qureshi Danish J. now owns 4,911,050 shares of LifeStance Health Group Inc, valued at $76,882 using the latest closing price.
Pantaleoni Pablo, the Chief Digital Officer of LifeStance Health Group Inc, sale 10,116 shares at $5.93 during a trade that took place back on Apr 01 ’24, which means that Pantaleoni Pablo is holding 1,299,927 shares at $59,988 based on the most recent closing price.
Stock Fundamentals for LFST
Current profitability levels for the company are sitting at:
- -0.18 for the present operating margin
- 0.27 for the gross margin
The net margin for LifeStance Health Group Inc stands at -0.18. The total capital return value is set at -0.09. Equity return is now at value -12.64, with -8.23 for asset returns.
Based on LifeStance Health Group Inc (LFST), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -0.05. The debt to equity ratio resting at 0.23. The interest coverage ratio of the stock is -8.87.
Currently, EBITDA for the company is -106.91 million with net debt to EBITDA at -4.01. When we switch over and look at the enterprise to sales, we see a ratio of 2.94. The receivables turnover for the company is 8.4for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.11.
Conclusion
In a nutshell, LifeStance Health Group Inc (LFST) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
